Medical Director, Neurology
23 days ago
Stevenage
Spur's proprietary, protein-engineered GCase85 molecule, utilized in our ongoing Gaucher clinical trial, demonstrates continued expression out past 1 year of infusion with a favorable benefit:risk ...